- Home
- FBIO vs VCIG Comparison
FBIO vs VCIG Comparison
Compare FBIO & VCIG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FBIO | VCIG |
|---|---|---|
| Founded | 2006 | 2013 |
| Country | United States | Malaysia |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Diversified Commercial Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 88.7M | 4.0M |
| IPO Year | N/A | 2023 |
Fundamental Metrics
Financial Performance| Metric | FBIO | VCIG |
|---|---|---|
| Price | $3.60 | $0.58 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $16.50 | N/A |
| AVG Volume (30 Days) | 519.4K | ★ 2.9M |
| Earning Date | 11-14-2025 | 01-21-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.98 |
| Revenue | ★ $62,303,000.00 | $32,903,041.00 |
| Revenue This Year | $29.71 | N/A |
| Revenue Next Year | $49.34 | N/A |
| P/E Ratio | ★ N/A | $0.59 |
| Revenue Growth | N/A | ★ 24.77 |
| 52 Week Low | $1.33 | $0.55 |
| 52 Week High | $4.20 | $1,290.00 |
Technical Indicators
Market Signals| Indicator | FBIO | VCIG |
|---|---|---|
| Relative Strength Index (RSI) | 72.57 | 30.42 |
| Support Level | $3.31 | $0.55 |
| Resistance Level | $3.75 | $0.68 |
| Average True Range (ATR) | 0.21 | 0.12 |
| MACD | 0.08 | 0.02 |
| Stochastic Oscillator | 89.73 | 2.93 |
Price Performance
Historical ComparisonAbout FBIO Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.
About VCIG VCI Global Limited
VCI Global Ltd is a holding company. The principal activities of the Company and its subsidiaries are the provision of business Strategy consultancy and technology development. The firm organized its consulting services into three main segments: Business Strategy Consultancy; Technology development, solutions and consultancy; and Others. It derives the majority of its revenue from the Business Strategy Consultancy segment, which focuses on listing solutions, investor relations, and boardroom strategies consultancy.